Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mroz

Showing results (41-50 of 187) with videos related to

Pageof 19
Sort By:
American Journal of Industrial Medicine|May 28, 2003
Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium diseaseLisa A Maier, Lori A Kittle, Margaret M Mroz, et al.
Physical Therapy|January 3, 2021
Rehabilitation Intensity and Patient Outcomes in Skilled Nursing Facilities in the United States: A Systematic ReviewRachel A Prusynski, Allison M Gustavson, Siddhi R Shrivastav, et al.
Archives of Physical Medicine and Rehabilitation|September 26, 2017
Home Health Agency Characteristics and Quality Outcomes for Medicare Beneficiaries With Rehabilitation-Sensitive ConditionsTracy M Mroz, Ann Meadow, Elizabeth Colantuoni, et al.
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|April 25, 2018
Occupational Therapy and Primary Care: Updates and TrendsAshley D Halle, Tracy M Mroz, Donald J Fogelberg, et al.
Chest|January 10, 2024
Sarcoidosis in the Military May Be Chronic Beryllium DiseaseLisa A Maier, Margaret M Mroz, Nancy Lin, et al.
Human Immunology|December 3, 2014
p38 Mitogen-Activated Protein Kinase in beryllium-induced dendritic cell activationL Li, Z Huang, M Gillespie, et al.
Chemical Science|January 19, 2026
Expanding the chemical space of ionic liquids using conditional variational autoencodersGaopeng Ren, Austin M Mroz, Frederik Philippi, et al.
European Journal of Medical Research|February 17, 2010
Nuclear HSP90 and HSP70 in COPD patients treated with formoterol or formoterol and corticosteroidsA Holownia, R M Mroz, A Kielek, et al.
European Journal of Medical Research|February 17, 2010
Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapyA Holownia, R M Mroz, A Kolodziejczyk, et al.
European Journal of Medical Research|February 17, 2010
Increased levels of Treg cells in bronchoalveolar lavage fluid and induced sputum of patients with active pulmonary sarcoidosisR M Mroz, M Korniluk, A Stasiak-Barmuta, et al.
Pageof 19

Showing results (41-50 of 187) with videos related to

Sort By:
Pageof 19
American Journal of Industrial Medicine|May 28, 2003
Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium diseaseLisa A Maier, Lori A Kittle, Margaret M Mroz, et al.
Physical Therapy|January 3, 2021
Rehabilitation Intensity and Patient Outcomes in Skilled Nursing Facilities in the United States: A Systematic ReviewRachel A Prusynski, Allison M Gustavson, Siddhi R Shrivastav, et al.
Archives of Physical Medicine and Rehabilitation|September 26, 2017
Home Health Agency Characteristics and Quality Outcomes for Medicare Beneficiaries With Rehabilitation-Sensitive ConditionsTracy M Mroz, Ann Meadow, Elizabeth Colantuoni, et al.
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association|April 25, 2018
Occupational Therapy and Primary Care: Updates and TrendsAshley D Halle, Tracy M Mroz, Donald J Fogelberg, et al.
Chest|January 10, 2024
Sarcoidosis in the Military May Be Chronic Beryllium DiseaseLisa A Maier, Margaret M Mroz, Nancy Lin, et al.
Human Immunology|December 3, 2014
p38 Mitogen-Activated Protein Kinase in beryllium-induced dendritic cell activationL Li, Z Huang, M Gillespie, et al.
Chemical Science|January 19, 2026
Expanding the chemical space of ionic liquids using conditional variational autoencodersGaopeng Ren, Austin M Mroz, Frederik Philippi, et al.
European Journal of Medical Research|February 17, 2010
Nuclear HSP90 and HSP70 in COPD patients treated with formoterol or formoterol and corticosteroidsA Holownia, R M Mroz, A Kielek, et al.
European Journal of Medical Research|February 17, 2010
Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapyA Holownia, R M Mroz, A Kolodziejczyk, et al.
European Journal of Medical Research|February 17, 2010
Increased levels of Treg cells in bronchoalveolar lavage fluid and induced sputum of patients with active pulmonary sarcoidosisR M Mroz, M Korniluk, A Stasiak-Barmuta, et al.
Pageof 19